Avidity Partners Management as of March 31, 2026
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 45 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dianthus Therapeutics (DNTH) | 35.8 | $177M | 2.1M | 83.92 | |
| Cg Oncology (CGON) | 17.7 | $87M | 1.3M | 67.68 | |
| Oruka Therapeutics (ORKA) | 7.6 | $37M | 760k | 49.05 | |
| Perspective Therapeutics Com New (CATX) | 5.1 | $25M | 6.0M | 4.17 | |
| Jade Biosciences Com New (JBIO) | 4.0 | $20M | 1.4M | 14.05 | |
| Enliven Therapeutics (ELVN) | 3.2 | $16M | 400k | 39.20 | |
| Teva Pharmaceutical Industries (TEVA) | 2.7 | $14M | 450k | 30.12 | |
| Context Therapeutics (CNTX) | 2.7 | $13M | 5.0M | 2.62 | |
| Repligen Corporation (RGEN) | 1.9 | $9.2M | 78k | 117.82 | |
| Palvella Therapeutics Inc Ne (PVLA) | 1.8 | $8.7M | 70k | 124.65 | |
| Medtronic SHS (MDT) | 1.8 | $8.7M | 100k | 86.65 | |
| Vir Biotechnology (VIR) | 1.7 | $8.5M | 950k | 8.96 | |
| Aktis Oncology | 1.7 | $8.4M | 469k | 17.89 | |
| Immunic (IMUX) | 1.5 | $7.4M | 6.7M | 1.11 | |
| Dex (DXCM) | 1.1 | $5.7M | 90k | 62.80 | |
| Encompass Health Corp (EHC) | 0.8 | $4.1M | 42k | 96.73 | |
| Boston Scientific Corporation (BSX) | 0.8 | $3.8M | 60k | 62.75 | |
| Tenax Therapeutics Com New (TENX) | 0.7 | $3.5M | 216k | 15.99 | |
| Gilead Sciences (GILD) | 0.6 | $2.8M | 20k | 139.37 | |
| Phathom Pharmaceuticals (PHAT) | 0.6 | $2.8M | 249k | 11.11 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.5 | $2.6M | 464k | 5.57 | |
| Centene Corporation (CNC) | 0.5 | $2.3M | 70k | 32.74 | |
| Satellos Bioscience | 0.4 | $2.2M | 388k | 5.63 | |
| Scynexis Com New (SCYX) | 0.4 | $1.9M | 2.1M | 0.92 | |
| Natera (NTRA) | 0.4 | $1.8M | 9.0k | 199.99 | |
| Icon SHS (ICLR) | 0.4 | $1.8M | 16k | 110.66 | |
| Kenvue (KVUE) | 0.3 | $1.7M | 100k | 17.24 | |
| Corvus Pharmaceuticals (CRVS) | 0.3 | $1.7M | 115k | 14.63 | |
| Hims & Hers Health Com Cl A (HIMS) | 0.3 | $1.6M | 75k | 20.76 | |
| Revolution Medicines (RVMD) | 0.3 | $1.5M | 15k | 97.25 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.3 | $1.4M | 30k | 48.20 | |
| Genmab A/s -sp Sponsored Ads (GMAB) | 0.3 | $1.3M | 50k | 26.83 | |
| Corcept Therapeutics Incorporated (CORT) | 0.2 | $1.2M | 30k | 40.31 | |
| Tempus Ai Cl A (TEM) | 0.2 | $1.1M | 25k | 45.22 | |
| Abivax Sa- Sponsored Ads (ABVX) | 0.2 | $1.1M | 10k | 111.35 | |
| UnitedHealth (UNH) | 0.2 | $1.0M | 3.8k | 270.59 | |
| Intellia Therapeutics (NTLA) | 0.2 | $962k | 75k | 12.82 | |
| Oddity Tech Ltd-cl A Shs Cl A (ODD) | 0.2 | $937k | 70k | 13.38 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.2 | $932k | 50k | 18.64 | |
| Peloton Interactive Inc-a Cl A Com (PTON) | 0.2 | $858k | 200k | 4.29 | |
| Anteris Technologies Global (AVR) | 0.2 | $833k | 150k | 5.55 | |
| Arbutus Biopharma (ABUS) | 0.1 | $563k | 125k | 4.50 | |
| Bridgebio Oncology Therapeut (BBOT) | 0.1 | $393k | 44k | 8.95 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $289k | 13k | 22.26 | |
| Trevi Therapeutics Com Cl A (TRVI) | 0.0 | $80k | 6.7k | 11.93 |
